Boston, November 2 (ots/PRNewswire) - - This Landmark Study Also Shows Response at 12 Weeks is a Powerful Predictor of Eventual Treatment Success. Roche today announced final results from the REPEAT study, which demonstrate that treatment with once-weekly PEGASYS(R) (peginterferon alfa-2a(40KD)) and ...
Basel, Switzerland, November 2 (ots/PRNewswire) - - Roche Progresses R1626 Into Phase IIb Study Called POLI 1 R1626, one of Roche's new investigational drugs for hepatitis C (HCV), has shown promising antiviral efficacy when given in combination with PEGASYS(R) (peginterferon alfa-2a (40KD)) and COPEGUS(R) (ribavirin), according to results being presented at ...
Brussels (ots/PRNewswire) - First study to investigate the protective effect of a lipid-lowering agent on diabetic eye disease to be published on-line in Lancet, Tuesday, 6th November 2007 Diabetic eye disease (called diabetic retinopathy) is the leading cause of vision loss in adults - affecting about 25 ...
Paris (ots/PRNewswire) - - Novel Compound Offers Hope to Patients not Adequately Responding to Laxative Treatment Data presented for the first time today at the international gastroenterology meeting UEGW (United European Gastroenterology Week) confirm the effectiveness and safety of RESOLOR(R) ...
Lugano (ots) - Oral Formulations of 5-HT3 receptor Antagonists Represent Approximately 10% of the Day-of-Chemotherapy Market - Helsinn Healthcare SA, a privately owned Swiss pharmaceutical group, and its partner MGI PHARMA, INC., (Nasdaq: MOGN), a biopharmaceutical company focused in oncology and acute care, ...
Irvine, California (ots/PRNewswire) - IsoTis, Inc. (NASDAQ: ISOT) ("IsoTis"), an orthobiologics company, today announced that, at the special meeting of stockholders re-convened earlier today, IsoTis stockholders have approved the acquisition of IsoTis by Integra LifeSciences Holdings Corporation (NASDAQ: IART) ("Integra") pursuant to an agreement and plan of merger dated as of August 6, 2007. The acquisition is ...
Toronto (ots/PRNewswire) - Dalton Medicinal Chemistry Partners, the Medicinal Chemistry arm of Dalton Pharma Services, announces that it has achieved a targeted milestone in its Medicinal Chemistry agreement with Boehringer Ingelheim (Canada) Ltd. The milestone achievement triggered payment of an undisclosed ...
Basel, Switzerland (ots/PRNewswire) - A new study on pain published today has found that subcutaneous (SC) injections of the new renal anaemia therapy MIRCERA is associated with significantly less pain immediately after injection than SC darbepoetin-alfa (Aranesp).(1) These findings are important because to date there has been minimal data regarding SC injection ...
Irvine, California (ots/PRNewswire) - - Less Than 40,000 Additional "FOR" Votes Required for Integra Merger IsoTis, Inc. (NASDAQ: ISOT) ("IsoTis"), an orthobiologics company, today announced that it has adjourned its special meeting of stockholders again, to Monday, October 29, 2007, to approve the acquisition of IsoTis by Integra LifeSciences Holdings Corporation (NASDAQ: IART) ("Integra") pursuant to an ...
Irvine, California (ots/PRNewswire) - - Less than 100,000 Additional "FOR" Votes Required for Integra Merger IsoTis, Inc. (NASDAQ: ISOT) ("IsoTis"), an orthobiologics company, today reported that less than 100,000 votes "FOR" are needed to approve the acquisition of IsoTis by Integra LifeSciences Holdings Corporation (NASDAQ: IART) ("Integra") pursuant to an agreement and plan of merger dated as of August 6, ...
Madrid, Spain (ots/PRNewswire) - - For Non-U.S. Media New data from the combined RESIST studies (RESIST-1 and RESIST-2) show that Aptivus(R) (tipranavir), used with Norvir (ritonavir), provides a superior and durable treatment response for up to three years in treatment- experienced HIV patients versus ...
Irvine, California (ots/PRNewswire) - - Less Than 350,000 Additional Votes "FOR" Required for Integra Merger IsoTis, Inc. (NASDAQ: ISOT) ("IsoTis"), an orthobiologics company, today announced that it has adjourned the special meeting of stockholders again, to October 26, 2007, to approve the acquisition of IsoTis by Integra LifeSciences Holdings Corporation (NASDAQ: IART) ("Integra") pursuant to an agreement ...
TRB Chemedica International S.A.
Geneva (ots) - TRB Chemedica International S.A. has issued legal proceedings against Gilead Science Limited in a dispute over the distribution rights of their products Viread, Hepsera, Truvada and Emtriva for Switzerland. TRB Chemedica International S.A., a small, family-owned Swiss pharmaceutical company based in Geneva, was granted exclusive rights by ...
London (ots/PRNewswire) - Data from two observational studies of over 470,000 patients taking statins in routine clinical practice investigating the incidence of cardiovascular events in patients taking CRESTOR(TM) (rosuvastatin) and other statins were presented today at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 10th Annual ...
Paris (ots/PRNewswire) - Sanofi-aventis announced today that the Japanese Ministry of Health, Labor and Welfare (MHLW) has granted approval for a Supplemental New Drug Application (sNDA) for the indication of "Acute coronary syndrome (unstable angina pectoris, non-ST elevation myocardial infarction) for which ...
Basel, Switzerland (ots/PRNewswire) - - MAXIMA Findings in the Lancet Affirm Ability to Maintain Haemoglobin Levels With Less Frequent Dosing A pivotal study published today in the Lancet has shown that dialysis patients can be effectively switched from frequently dosed anaemia drugs to an innovative new ...
Calgary, Canada (ots/PRNewswire) - - Canadian Biotechnology Company has now Established Commercial Levels of Both Native Apo AI and Apo AI(Milano) variant in Safflower Seed Lines SemBioSys Genetics Inc. (TSX:SBS), a biotechnology company developing a portfolio of therapeutic proteins for metabolic and cardiovascular diseases , today announced that it has ...
Gaithersburg, Maryland and Hilden, Germany (ots/PRNewswire) - The first randomized, controlled study in North America of HPV testing as a stand-alone screen concluded that it is almost 40 percent more accurate than traditional cytology (the Pap "smear") in identifying women with advanced cervical disease, according to a report published today in The New England ...
Basel, Switzerland (ots/PRNewswire) - Ten abstracts providing new analyses of data from six major Phase III renal anaemia studies for MIRCERA(R) will be published/presented at the upcoming 40th Annual Meeting of the American Society of Nephrology (ASN) in San Francisco on 2 - 5 November. Among the highlights will be new analyses from 'maintenance' studies ...
Shire Pharmaceuticals Group Plc
Philadelphia (ots/PRNewswire) - At the U.S. Food and Drug Administration's (FDA's) Cardiovascular and Renal Drugs Advisory Committee meeting today, the majority of members voted to recommend the use of phosphate binders, including Shire Pharmaceuticals' non-calcium FOSRENOL(R) (lanthanum carbonate), to treat ...
Irvine, California (ots/PRNewswire) - - Conference Calls to Answer Questions About Stockholder Meeting October 23 IsoTis, Inc. (NASDAQ: ISOT) ("IsoTis"), an orthobiologics company, today announced the interim tabulation results of the special stockholders meeting held on October 11, 2007 and adjourned to October 23, 2007. Prior to October 11, 2007, approximately 2,555,000 shares, 36 percent of the shares ...
Vienna, Austria (ots/PRNewswire) - Valdoxan(R) (agomelatine), the first melatonergic antidepressant, is an effective, long-term treatment for Major Depressive Disorder (MDD) according to new data presented today at the European College of Neurospsychopharmacology (ECNP) annual congress. The new international ...
Basel (ots) - At the closing of the 4th European "Tobacco or Health" conference 2007 in Basel today, more than 500 experts from 62 countries requested effective protection against passive smoking. Smoke-free indoor areas which are accessible to the public can easily be introduced without the need of reserving special smoking areas. Even smokers generally agree on this. This is what former Norwegian health minister, ...
Calgary, Canada (ots/PRNewswire) - - Novel ApoA-I/HDL Raising Drug, RVX-208, to be Featured in Oral Presentation Resverlogix Corp. ("Resverlogix") (TSX:RVX) is pleased to announce that tommorrow it is making an oral presentation highlighting key scientific data of its lead clinical molecule, RVX-208, at the International Atherosclerosis Society (IAS) Workshop on HDL. The presentation titled "A novel drug that ...
Irvine, California (ots/PRNewswire) - IsoTis, Inc. (NASDAQ: ISOT) ("IsoTis"), an orthobiologics company, today announced that it has adjourned the special meeting of stockholders it called to approve the acquisition of IsoTis by Integra LifeSciences Holdings Corporation (NASDAQ: IART) ("Integra") pursuant to an agreement and plan of merger dated as of August 6, 2007. The special meeting of stockholders was held at ...
Basel (ots) - Tobacco or Health. This is not a question but a revelation. Each year, over 5 million people globally die from the consequences of active and passive tobacco consumption - over 650 000 people in the European Union alone. About 8 000 people die per year in Switzerland as a consequence. What are ...
Toronto, Canada (ots/PRNewswire) - CBM President Professor Allen Foster met with the Director-General Dr Margaret Chan, for the World Health Organizations global initiative to eliminate avoidable blindness "Vision 2020: The Right to Sight" on the eve of World Sight Day 2007 at WHO Headquarters Geneva. Dr. Chan thanked CBM for their longstanding 20 year partnership and support, both financially and with technical ...
Leuven, Belgium (ots/PRNewswire) - - EUFAMI Survey Shows Carers Across Europe Believe in Remission as a Realistic Treatment Goal for Many People Living With Schizophrenia A large majority of families who care for someone with schizophrenia are confident that many people with the disease can lead ...
Collegeville, Pennsylvania (ots/PRNewswire) - Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced today the signing of a definitive agreement under which it has acquired Haptogen Ltd., a Scottish company based in Aberdeen that is focused on the discovery of biopharmaceutical therapies. This acquisition significantly increases Wyeth's already ...
Pittsburgh (ots/PRNewswire) - Mylan (NYSE: MYL) announced today that it has completed its acquisition of Merck KGaA's generics business ("Merck Generics") to become one of the largest quality generics and specialty pharmaceuticals companies in the world. Mylan and Merck KGaA initially announced the signing of a definitive agreement under which Mylan would acquire Merck Generics for EUR 4.9 billion (US$6.8 billion) ...